Current Posters and presentations
Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations include:
February 2012
25th Annual Park City Combined AP/CP Pathology Update
January 30–February 3, 2012
Smock KJ—Presentation
Smock KJ. Coagulation testing: A case-based update.
Grenache DG—Presentation
Grenache DG. Non-invasive assessment of liver fibrosis.
Society of Critical Care Medicine (SCCM)
San Diego, CA, February 4–8, 2012
Tebo A—Poster
Py L, Tebo A, Godshall A. Laboratory confirmation of treatment effectiveness for NMDA receptor encephalitis in absence of clinical findings.
January 2012
Winter Conference on Plasma Spectrochemistry
January 8–14, 2012, Tucson, AZ
Travis JJ, McMillin GA, Strathmann FG—Poster
Travis JJ, McMillin GA, Strathmann FG. Elemental interference attributed to iodine in human urine.
Mass Spectrometry: Applications to the Clinical Lab (MSACL)
January 14–18, 2012, San Diego, CA
Fisher MA, Khot PD—Presentation
Fisher MA, Khot PD. Analysis of the 10 percent rule in bacterial identification by MALDI-TOF M.
Ray JA, Kushnir MM, Bunker A, Rockwood AL, Meikle AW—Poster
Ray JA, Kushnir MM, Bunker A, Rockwood AL, Meikle AW. Direct measurement of free estradiol in human serum by equilibrium dialysis-LC-MS/MS and reference intervals of free estradiol in women.
Clark ZD, Strathmann FG, McMillin GA—Poster
Clark ZD, Strathmann FG, McMillin GA. Urine profiles of oxycodone, noroxycodone, oxymorphone, and noroxymorphone.
American Federation for Medical Research (AMFR)
January 25–28, 2012, Carmel, CA
Kushnir MM, Rockwood AL, Meikle AW—Presentation
Kushnir MM, Rockwood AL, Roberts AL, Hoofnagle AN, Meikle AW. Accurate measurement of thyroglobulin in serum in presence of anti-thyroglobulin autoantibodies.
Martins TB, Augustine NH, Hill HR—Poster
Martins TB, Augustine NH, Kumanovics A, Hill HR. Identification of CD40 ligand and icos defects in patients with primary immunodefciencies.
December 2011
San Antonio Breast Cancer Symposium
San Antonio, TX, December 6–10, 2011
Ebbert MTW, Bastien RRL, Bernard PS—Poster
Martin M, Rodríguez-Lescure A, Stijleman IJ, Munárriz B, Ruíz-Borrego M, Davis C, Crespo C, Rodríguez CA, Ebbert MTW, Álvarez I, Furió V, Bastien RRL, García AM, Cheang MC, Palacios J, Ellis MJ, Carrasco E, Casas MI, Caballero R, Perou C, Bernard PS. PAM50 proliferation index predicts response to weekly adjuvant Paclitaxel in node -positive operable breast cancer.
American Society for Hematology (ASH)
San Diego, CA, Dec 10–13, 2011
Salama M, Kohan J—Poster
Salama M, Graham W, Berno J, Kohan J, Zhan F, Tricot G, Zangari G. Bone effect of botezomib in patients with relapse and smoldering myeloma; a computer assisted image analysis study of bone marrow core biopsies.
Salama M—Poster
Salama M, Lange H, Landis N, Potts S. Characterization of spatial distribution of myeloma cells and their microenvironment in bone marrow; a computer assisted study using novel whole slide image analysis technology.
Szankasi P, Kelley TW—Poster
Spencer DH, Abel H, Szankasi P, Kelley TW, Kulkami S, Watson MA, Pfeifer JD, Duncavage EJ. Detection of FLT3 internal tandem duplications in acute myeloid leukemia by targeted multi-gene next generation sequencing.
Kelley TW, Szankasi P—Poster
Khorashad J, Kelley TW, Szankasi P, Adrian LT, Eide CA, Zabriskie M, Lange T, Kraft IL, Eiring AL, O'Hare T, Deininger MW. Frequency and clonality of BCR-ABL compound mutations in chronic myeloid leukemia.
Perkins SL—Poster
Cairo MS, Day N, Goldman S, Sanger WG, Harrison L, Lim MS, Miles RR, Perkins SL. Genomic pathways and potential therapeutic targets in pediatric Burkitt lymphoma (PBL): a children’s oncology group report.
Kelley TW, Schumacher JA, Szankasi P—Poster
Kelley TW, Efimova O, Schumacher JA, Szankasi P. Helios is not a reliable marker to distinguish thymus-derived natural regulatory T-cells from induced regulatory T-cells.
Kelley TW, Reading S, Prchal JT—Poster
Jovanovic JV, Vannucchi AM, Lippert E, Oppliger Leibundgut E, Maroc N, Hermouet S, Nickless G, Cassinat B, Guglielmelli P, van der Reijden B, Bench A, Tobal K, Wilkins B, Cuthill K, Ivey A, Yeoman K, Percy MJ, Schwemmers S, Gruender A, Kelley TW, Reading S, Pancrazzi A, McMullin MF, Pahl HL, Harrison CN, Prchal JT, Chomienne C, Kiladjian JJ, Barbui T, Grimwade D. Reaction (Q-PCR) assays to track treatment response in patients with JAK2-V617F associated myeloproliferative neoplasms: a joint european LeukemiaNet/MPN&MPNr-EuroNet study.
Schumacher JA, Kelley TW, Perkins S, Prchal JT—Poster
Kim SJ, Swierczek S, Schumacher JA, Kelley TW, Perkins S, Prchal JT. Single center experience with screening for Jak2 V617F, cMPL W515K, cMPL W515L, and Jak2 L611V mutations in MPN.
Perkins SL—Poster
Goldman S, Galardy PJ, Smith L, Perkins SL, Shiramizu B, Gross T, Sanger WG, Harrison L, Cairo MS. The efficacy of rasburicase and rituximab combined with FAB chemotherapy in children and adolescents with newly diagnosed stage III/IV, BM+ and CNS+ Mature B-NHL: a children’s oncology group report.
November 2011
Association for Molecular Pathology (AMP)
Grapevine, TX, Nov 17–19, 2011
Geiersbach KB, Herrmann MG, Paxton CN—Poster
Adey NB, Parry RJ, Paxton CN, Herrmann MG, Geiersbach KB. A milling machine based meso level dissection device for accurate, rapid, and economical recovery of tissue from slides.
Schumacher JA, Szankasi P, Prchal JT, Kelley TW—Poster
Schumacher JA, Kim S P, Prchal JT, Kelley TWJ, Szankasi. A quantitative, pyrosequencing-based assay to detect MPL mutations.
Melis R, Lewis T, McMillin G, Lyon E, Slev P, Swensen J—Poster
Melis R, Lewis T, McMillin G, Lyon E, Slev P, Swensen J. CNV and incomplete linkage disequilibrium interference with the HCP5 genotyping assay for abacavir hypersensitivity.
Voelkerding KV—Presentation
Voelkerding KV. Exome and whole genome sequencing in a clinical research settings.
Vaughn CP, Swensen JJ, Baker CL, Samowitz WS—Poster
Vaughn CP, Swensen JJ, Baker CL, Samowitz WS. Frequency of 3' deletions in PMS2.
Durtschi JD, Ridge PG, Crockett DK—Presentation
Durtschi JD, Ridge PG, Crockett DK. Next generation sequencing bioinformatics: from data analysis to reporting.
Paxton C, Jama M, Wilson AR, Lyon E, Jarboe E, Geiersbach K—Poster
Furtado LV, Paxton C, Jama M, Wilson AR, Lyon E, Jarboe E, Thaker HM, Geiersbach K. Performance of STR genotyping in samples referred for molar pregnancy testing.
Szankasi P, Kelley TW—Poster
Duncavage E, Abel H, Szankasi P, Kelley TW, Pfeifer J. Targeted next-generation sequencing based identification of clinically significant gene mutations and translocations in leukemia.
Baker CL, Margraf R, Durtschi J, Donahue WL, Vaughn CP, Voelkerding K, Samowitz WS—Poster
Baker CL, Margraf R, Durtschi J, Donahue WL, Vaughn CP, Voelkerding K, Samowitz WS. Next-generation sequencing of FFPE tissue.
Newborn Screening and Genetic Testing Symposium
San Diego, CA, November 7–10, 2011
Jensen M, Schwarz EL, Pasquali M—Poster
Jensen M, Garn J, Haslip C, Keune F, Dymerski M, Wright E, Hunt P, Tanksley S, Beischel L, Soule C, Schwarz EL, Pasquali M. Second tier testing for disorders identified by tandem mass spectrometry in the mountain states region.
American Society of Cytopathology (ASC)
Baltimore, MD, Nov 4–8, 2011
Bentz JS, Collins BT, Smith GD—Presentation
Bentz JS, Collins BT, Smith GD. State of the art in cytomorpholgy and molecular diagnostics.
